trending Market Intelligence /marketintelligence/en/news-insights/trending/hk8hkjbutxvcnolu3slqma2 content esgSubNav
In This List

ImmunoPrecise names CEO to board, appoints global chief technology officer

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


ImmunoPrecise names CEO to board, appoints global chief technology officer

ImmunoPrecise Antibodies Ltd. added Jennifer Bath to its board, months after she became the company's president and CEO.

The Canadian clinical research organization also appointed Charles Wheelock as its global chief technology officer.

Wheelock has spent 16 years at Microsoft in various roles, most recently as a senior global technical account manager.